Table 4.

Demographic and clinical characteristics of patients in the validation groups.

	ACR (n= 25)	No-ACR (n=21)
Age (median (range))*	52 (19–72)	57 (40–70)
Male/female	13/12	13/8
Liver disease**
HCV	3	2
Alcohol	4	4
NASH	0	3
PSC	5	3
PBC	2	2
AIH	2	0
Cholangiocarcinoma	2	6
Hepatocellular carcinoma	2	3
Acute fulminant hepatitis	3	0
Wilson’s disease	1	0
Amyloidosis	2	0
Oxalosis	1	0
Hepatic artery thrombosis	2	1
A-1 Antitrypsin deficiency	0	1
Cryptogenic	0	1

^*P= 0.143

^**Some patients have more than one diagnosis